lipidil ez tablet
bgp pharma ulc - fenofibrate - tablet - 145mg - fenofibrate 145mg - fribic acid derivatives
nu-feno-micro capsule
nu-pharm inc - fenofibrate - capsule - 67mg - fenofibrate 67mg - fribic acid derivatives
sandoz fenofibrate e tablet
sandoz canada incorporated - fenofibrate - tablet - 48.0mg - fenofibrate 48.0mg - fribic acid derivatives
sandoz fenofibrate e tablet
sandoz canada incorporated - fenofibrate - tablet - 145.0mg - fenofibrate 145.0mg - fribic acid derivatives
taro-fenofibrate e tablet
sun pharma canada inc - fenofibrate - tablet - 145mg - fenofibrate 145mg - fribic acid derivatives
mint-fenofibrate e tablet
mint pharmaceuticals inc - fenofibrate - tablet - 145mg - fenofibrate 145mg - fribic acid derivatives
lipantil supra 215 milligram film coated tablet
bgp products ltd - fenofibrate - film coated tablet - 215 milligram - fibrates
lipantil supra 215 mg, film-coated tablet
mylan ire healthcare limited - fenofibrate - film-coated tablet - 215 milligram(s) - fibrates; fenofibrate
lipantil micro 200 mg capsules, hard
primecrown 2010 limited - fenofibrate - capsule, hard - 200 milligram(s) - fibrates; fenofibrate - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: severe hypertriglyceridaemia with or without low hdl cholesterol, mixed hyperlipidaemia when a statin is contraindicated or not tolerated, mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.
lipantil micro 200mg capsules, hard.
bgp products ltd - fenofibrate. - capsule, hard. - 200mg - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.